Following a 10-day expansion, evaluation of specificity via IFN-γ ELISPOT demonstrated specificity to mycobacterial antigens in two of the seven patients with PID (Figure 5A, Supplemental Table 6). This evidence concerns the gene IFNG and pelvic inflammatory disease.